Evidence map›Paper›PMID 21490707›Full record

SynthesisPLoS genetics2011

Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption.

Marilyn C Cornelis, Keri L Monda, Kai Yu, Nina Paynter, Elizabeth M Azzato, Siiri N Bennett, Sonja I Berndt, Eric Boerwinkle, Stephen Chanock, Nilanjan Chatterjee and 22 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in PLoS genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 14 pooled it
17.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 14 syntheses or guidelines pooled it, 231 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Journal of the American Society of Nephrology : JASN · 2017
    Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 9 institutions in 2 countries.

Marilyn C CornelisDepartment of Nutrition, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Keri L Monda
Kai Yu
Nina Paynter
Elizabeth M Azzato
Siiri N Bennett
Sonja I Berndt
Eric Boerwinkle
Stephen Chanock
Nilanjan Chatterjee
David Couper
Gary Curhan
Gerardo Heiss
Frank B Hu
David J Hunter
Kevin Jacobs
Majken K Jensen
Peter Kraft
Maria Teresa Landi
Jennifer A Nettleton
Mark P Purdue
Preetha Rajaraman
Eric B Rimm
Lynda M Rose
Nathaniel Rothman
Debra Silverman
Rachael Stolzenberg-Solomon
Amy Subar
Meredith Yeager
Daniel I Chasman
Rob M van Dam
Neil E Caporaso
National Cancer Institute · USHarvard University Press · USNational Institutes of Health · USUniversity of North Carolina at Chapel Hill · USBrigham and Women's Hospital · USThe University of Texas Health Science Center at Houston · USHarvard University · USNational University of Singapore · SGUniversity of Washington · US

Funding

Subject CollectionU10AA008401 · NIAAA · SUNY DOWNSTATE MEDICAL CENTER · PI Jacquelyn Leigh Meyers · 1989 to 2026
$162.7M
Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ROSNER, BERNARD A · 2000 to 2019
$77.8M
Institute for Clinical and Translational Research (UL1)UL1RR025005 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2007 to 2011
$75.8M
Validity of Diet and Activity Measures in WomenP01CA055075 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI SMITH-WARNER, STEPHANIE A · 1991 to 2009
$41.8M
Women's Health Study: Continued Follow-upR01CA047988 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI BURING, JULIE E., LEE, I-MIN · 1991 to 2014
$28.2M
Pharmacogenomics and Risk of Cardiovascular DiseaseU01HL069757 · NHLBI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI KRAUSS, RONALD M · 2001 to 2009
$24.7M
JH/CIDR Genotyping for Genome-Wide Association StudiesU01HG004438 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2007 to 2011
$24.2M
GENETIC SUSCEPTIBILITY TO CANCER IN MULTIETHNIC COHORTSR01CA063464 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 2001 to 2005
$23.2M
Multiethnic Cohort Study of Diet and CancerR37CA054281 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 2003 to 2012
$23.2M
A Center for GEI Association StudiesU01HG004424 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GABRIEL, STACEY · 2007 to 2010
$21.4M
Genome-Wide Association Analysis in Essential Hypertension (FEHGAS study)R01HL086694 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ARAVINDA CHAKRAVARTI · 2007 to 2026
$21.2M
The Collaborative Genetic Study of Nicotine DependenceP01CA089392 · NCI · WASHINGTON UNIVERSITY · PI BIERUT, LAURA J. · 2001 to 2012
$17.3M
CIHRIntramural NIH HHS Z01 CP010200NCI NIH HHS CA 047988NCI NIH HHS CA136792NCI NIH HHS CA 40356NCI NIH HHS CA54281NCI NIH HHS CA55075NCI NIH HHS CA63464NCI NIH HHS P01 CA055075NCI NIH HHS P01CA055075NCI NIH HHS P01 CA087969NCI NIH HHS P01CA087969NCI NIH HHS P01 CA089392NCI NIH HHS P01CA089392NCI NIH HHS R01 CA040356NCI NIH HHS R01 CA047988NCI NIH HHS R01 CA054281NCI NIH HHS R01 CA063464NCI NIH HHS R37 CA054281NCI NIH HHS U01 CA063464NCI NIH HHS U01 CA098233NCI NIH HHS U01 CA136792NCI NIH HHS U01-CA98233NCRR NIH HHS UL1 RR025005NCRR NIH HHS UL1RR025005NHGRI NIH HHS 01HG004735NHGRI NIH HHS HHSN268200782096CNHGRI NIH HHS U01 HG004399NHGRI NIH HHS U01HG004399NHGRI NIH HHS U01 HG004402NHGRI NIH HHS U01HG004402NHGRI NIH HHS U01 HG004415NHGRI NIH HHS U01HG004415NHGRI NIH HHS U01 HG004422NHGRI NIH HHS U01HG004422NHGRI NIH HHS U01 HG004423NHGRI NIH HHS U01HG004423NHGRI NIH HHS U01 HG004424NHGRI NIH HHS U01 HG004436NHGRI NIH HHS U01HG004436NHGRI NIH HHS U01 HG004438NHGRI NIH HHS U01HG004438NHGRI NIH HHS U01 HG004446NHGRI NIH HHS U01HG004446NHGRI NIH HHS U01 HG004726NHGRI NIH HHS U01HG004726NHGRI NIH HHS U01 HG004728NHGRI NIH HHS U01HG004728NHGRI NIH HHS U01 HG004729NHGRI NIH HHS U01HG004729NHGRI NIH HHS U01 HG004735NHGRI NIH HHS U01 HG004738NHGRI NIH HHS U01HG004738NHGRI NIH HHS U01HG04424NHLBI NIH HHS HL 043851NHLBI NIH HHS HL35464NHLBI NIH HHS HL69757NHLBI NIH HHS N01 HC055015NHLBI NIH HHS N01 HC055016NHLBI NIH HHS N01 HC055018NHLBI NIH HHS N01 HC055019NHLBI NIH HHS N01 HC055020NHLBI NIH HHS N01 HC055021NHLBI NIH HHS N01 HC055022NHLBI NIH HHS N01-HC-55015NHLBI NIH HHS N01-HC-55016NHLBI NIH HHS N01-HC-55018NHLBI NIH HHS N01-HC-55019NHLBI NIH HHS N01-HC-55020NHLBI NIH HHS N01-HC-55021NHLBI NIH HHS N01-HC-55022NHLBI NIH HHS R01 HL035464NHLBI NIH HHS R01 HL043851NHLBI NIH HHS R01 HL059367NHLBI NIH HHS R01 HL086694NHLBI NIH HHS R01HL086694NHLBI NIH HHS R01 HL087641NHLBI NIH HHS R01HL087641NHLBI NIH HHS R01HL59367NHLBI NIH HHS U01 HL069757NHLBI NIH HHS U19 HL069757NIAAA NIH HHS U10 AA008401NIAAA NIH HHS U10AA008401NIDA NIH HHS 01DA013423NIDA NIH HHS R01 DA013423NIDCR NIH HHS U01 DE018903NIDCR NIH HHS U01DE018903NIDCR NIH HHS U01 DE018993NIDCR NIH HHS U01DE018993NIDDK NIH HHS 5P01DK070756NIDDK NIH HHS P01 DK070756NIDDK NIH HHS R01 DK058845NIDDK NIH HHS R01DK058845PHS HHS AHG006033
6 · The paper itself

Abstract

We report the first genome-wide association study of habitual caffeine intake. We included 47,341 individuals of European descent based on five population-based studies within the United States. In a meta-analysis adjusted for age, sex, smoking, and eigenvectors of population variation, two loci achieved genome-wide significance: 7p21 (P = 2.4 × 10(-19)), near AHR, and 15q24 (P = 5.2 × 10(-14)), between CYP1A1 and CYP1A2. Both the AHR and CYP1A2 genes are biologically plausible candidates as CYP1A2 metabolizes caffeine and AHR regulates CYP1A2.

Indexed as

CaffeineCytochrome P-450 CYP1A2Genome-Wide Association StudyAdultAgedChromosomes, Human, Pair 15Chromosomes, Human, Pair 7Drinking BehaviorFemaleGenotypeHumansMaleMiddle AgedPolymorphism, Single NucleotideQuality ControlReceptors, Aryl HydrocarbonCaffeineCytochrome P-450 CYP1A2Receptors, Aryl Hydrocarbon

Identifiers

PMID21490707
PMCPMC3071630
OpenAlexW2147245308

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.